Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor receptor 3 pseudogene 4 (FGFR3P4) is a non-protein-coding pseudogene named for its sequence similarity to the FGFR3 gene. Unlike FGFR3, which encodes a transmembrane receptor tyrosine kinase involved in diverse signaling pathways related to cell growth, differentiation, and disease[4][1][2][3], FGFR3P4 does not produce a functional protein, is not involved in canonical biological signaling, and has no known role in disease or therapy. Pseudogenes like FGFR3P4 are typically non-functional genomic elements resulting from gene duplication or mutation. If you intended to ask about FGFR3 (Fibroblast growth factor receptor 3), this is a well-established drug target and biological receptor, but the molecule specified here (FGFR3P4) is not. For entries relating to actual drug targets, see information on FGFR3, not this pseudogene.
Not applicable; pseudogenes are not targeted by drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor receptor 3 pseudogene 4 (FGFR3P4).